HCA Healthcare, Inc. (NYSE:HCA – Free Report) – Investment analysts at KeyCorp increased their FY2026 earnings per share (EPS) estimates for HCA Healthcare in a research note issued on Tuesday, October 27th. KeyCorp analyst M. Gillmor now expects that the company will post earnings of $30.07 per share for the year, up from their previous forecast of $29.21. KeyCorp has an “Overweight” rating and a $490.00 price target on the stock. The consensus estimate for HCA Healthcare’s current full-year earnings is $30.15 per share. KeyCorp also issued estimates for HCA Healthcare’s Q4 2026 earnings at $8.11 EPS, Q1 2027 earnings at $7.41 EPS, Q2 2027 earnings at $7.84 EPS, Q3 2027 earnings at $7.59 EPS, Q4 2027 earnings at $8.48 EPS, FY2027 earnings at $31.32 EPS and FY2028 earnings at $35.11 EPS.
Other equities analysts have also issued research reports about the company. JPMorgan Chase & Co. dropped their price objective on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a report on Tuesday, July 7th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Leerink Partners reiterated an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a research note on Friday, September 18th. Finally, Barclays raised their target price on shares of HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 29th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $480.13.
Get Our Latest Research Report on HCA
HCA Healthcare Price Performance
Shares of NYSE:HCA opened at $462.52 on Monday. HCA Healthcare has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a market capitalization of $96.62 billion, a P/E ratio of 15.61, a P/E/G ratio of 1.56 and a beta of 1.11. The company’s fifty day moving average price is $438.88 and its 200 day moving average price is $444.76.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.96 earnings per share.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.34%.
Institutional Trading of HCA Healthcare
Several hedge funds and other institutional investors have recently made changes to their positions in HCA. BlackRock Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $5,069,974,000. Wellington Management Group LLP increased its stake in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares during the last quarter. Darsana Capital Partners LP raised its holdings in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare in the second quarter valued at $410,992,000. Finally, Jupiter Topco LLC bought a new position in HCA Healthcare during the 2nd quarter valued at $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Trending Headlines about HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Truist reaffirmed its “Buy” rating and raised its price target to $510 from $495, suggesting confidence in HCA’s prospects. Read More.
- Positive Sentiment: HCA plans a $300 million hospital in Cape Coral, Florida, with $31 million in city incentives. The project could support future capacity and growth, though it also entails significant investment. Cape Coral hospital article
- Neutral Sentiment: An HCA subsidiary plans to issue senior notes. The financing may support corporate needs, but the available report does not provide terms or indicate how much debt will be added. Senior notes offering
- Negative Sentiment: A report on HCA’s third-quarter payer mix highlights an estimated $400 million cost burden associated with a shift toward uninsured patients. Higher uncompensated-care costs could weigh on margins. Q3 revenue by payer article
- Negative Sentiment: Pomerantz LLP said it is investigating potential claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but the announcement adds legal and reputational uncertainty. Investor investigation announcement
- Negative Sentiment: A reported data breach affected about 55,000 people, creating potential privacy, remediation and reputational risks. Data breach report
About HCA Healthcare
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
